Drug class
Long-acting reversible acetylcholinesterase inhibitor; quaternary ammonium carbamate
Mechanism of action
Reversibly inhibits acetylcholinesterase, increasing acetylcholine concentrations at cholinergic synapses and enhancing neuromuscular transmission and parasympathetic activity.
General use cases
- Treatment of myasthenia gravis in product-authorised jurisdictions
- Treatment of underactive bladder/urinary retention due to detrusor hypocontractility in specific countries and formulations; local product information must be checked
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
